SG10201402352UA - Therapeutic compositions for treating cancers - Google Patents

Therapeutic compositions for treating cancers

Info

Publication number
SG10201402352UA
SG10201402352UA SG10201402352UA SG10201402352UA SG10201402352UA SG 10201402352U A SG10201402352U A SG 10201402352UA SG 10201402352U A SG10201402352U A SG 10201402352UA SG 10201402352U A SG10201402352U A SG 10201402352UA SG 10201402352U A SG10201402352U A SG 10201402352UA
Authority
SG
Singapore
Prior art keywords
cancer
therapeutic compositions
treating cancers
ganoderic acid
acid
Prior art date
Application number
SG10201402352UA
Inventor
Shwu-Bin Lin
Cheng-Po Huang
Teng-Hai Chen
Kuang-Dee Chen
Original Assignee
Double Crane Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Double Crane Biotechnology Co Ltd filed Critical Double Crane Biotechnology Co Ltd
Publication of SG10201402352UA publication Critical patent/SG10201402352UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

OF THE DISCLOSURE Disclosed herein is a composition that includes a novel combination of triterpenoids for the treatment or prophylaxis of a cancer. The triterpenoids includes at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), 5 ganoderic acid R (GAR), and ganodermic acid S (GMAS). The composition is suitable for the treatment or prophylaxis of colon cancer, hepatic cancer, breast cancer, lung cancer or leukemia. 29
SG10201402352UA 2013-05-28 2014-05-15 Therapeutic compositions for treating cancers SG10201402352UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/903,553 US9198922B2 (en) 2013-05-28 2013-05-28 Therapeutic composition for treating cancers

Publications (1)

Publication Number Publication Date
SG10201402352UA true SG10201402352UA (en) 2014-12-30

Family

ID=51985808

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201402352UA SG10201402352UA (en) 2013-05-28 2014-05-15 Therapeutic compositions for treating cancers

Country Status (2)

Country Link
US (1) US9198922B2 (en)
SG (1) SG10201402352UA (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3821949B1 (en) * 2019-11-13 2022-08-17 Trineo Biotechnology Co. Ltd Pharmaceutical composition for use in the treatment of a cancer associated with the activation of galectin-1

Also Published As

Publication number Publication date
US20140357604A1 (en) 2014-12-04
US9198922B2 (en) 2015-12-01

Similar Documents

Publication Publication Date Title
MX2021006531A (en) Rna containing composition for treatment of tumor diseases.
MX2016002544A (en) Compounds useful as immunomodulators.
PH12018502535A1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
MX2015011897A (en) Prodrugs of fumarates and their use in treating various deseases.
MY198613A (en) Nitrobenzyl derivatives of anti-cancer agents
PH12015502414A1 (en) Enhancer of zeste homolog 2 inhibitors
MX2015011752A (en) Methods of treating lung cancer.
MD4643C1 (en) Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same
MX2015016404A (en) Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brian tumor.
MY157341A (en) Methods and compositions for treating lung cancer
NZ726365A (en) Combinations for treating cancers
MX368903B (en) THERAPEUTIC COMPOUNDS and USES THEREOF.
CR20190519A (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds
PH12019550224A1 (en) Antitumoral compounds
MX2018006953A (en) Monomaleimide-functionalized platinum compounds for cancer therapy.
MX2019003694A (en) Methods of treating biliary tract cancer.
SG10201402352UA (en) Therapeutic compositions for treating cancers
TN2015000378A1 (en) Cabazitaxel and its use for treating metastatic prostate cancers
MX2016004094A (en) Pharmaceutical composition comprising capecitabine and cyclophosphamide.
WO2014180882A3 (en) Treatment of brain metastasis from cancer
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
MX2017014463A (en) Cabazitaxel and its use for treating cancer.
MX2017013669A (en) Compositions for the treatment of cancer.
IN2013DE03665A (en)
GB2553684A8 (en) Ethynylxanthines, preparation and use for cancer treatment